Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. boosted its position in Agilent Technologies, Inc. (NYSE:A) by 2.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 207,277 shares of the medical research company’s stock after buying an additional 4,535 shares during the period. Vaughan Nelson Investment Management L.P. owned approximately 0.07% of Agilent Technologies worth $23,625,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new stake in Agilent Technologies during the 4th quarter valued at approximately $549,158,000. Massachusetts Financial Services Co. MA raised its holdings in shares of Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after purchasing an additional 1,713,216 shares during the last quarter. AQR Capital Management LLC lifted its position in Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. boosted its holdings in Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares during the last quarter. Finally, Balyasny Asset Management L.P. boosted its holdings in Agilent Technologies by 192.0% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock valued at $192,204,000 after purchasing an additional 928,821 shares during the last quarter.

Agilent Technologies Price Performance

NYSE:A opened at $126.34 on Tuesday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The stock’s 50-day moving average price is $121.70 and its 200-day moving average price is $126.60. The stock has a market capitalization of $35.68 billion, a PE ratio of 25.37, a price-to-earnings-growth ratio of 2.26 and a beta of 1.26.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. Agilent Technologies’s quarterly revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 6 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on A shares. Morgan Stanley reduced their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. TD Cowen lifted their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Barclays upped their price objective on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Finally, Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $160.93.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.